Literature DB >> 11334979

Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein.

M Bianchini1, M Radrizzani, M G Brocardo, G B Reyes, C Gonzalez Solveyra, T A Santa-Coloma.   

Abstract

Oligonucleotide aptamer(s), obtained by using the SELEX procedure, has been used as reagents to recognize different molecules with high affinity and specificity. However, until recently, it was not possible to obtain oligonucleotide-based reagents able to recognize proteins with high specificity in assays typical of antibodies, such as immunohistochemistry, Western blotting and immunoprecipitations. Here, we show the results obtained by applying the strategy of "target switching" to obtain specific polyclonal and monoclonal oligobodies against the protein ERK2. We were able to develop highly specific polyclonal oligobodies by using only one selection step with a temporary target and one selection step with the final target (ERK2). Since only two selection steps were required, these results demonstrate that it is possible to obtain specific reagents against a protein without a need for an "in vitro evolution" using many selection steps, or error-prone polymerases. After one additional selection step, the polyclonal oligobodies were cloned to obtain a highly specific monoclonal oligobody.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334979     DOI: 10.1016/s0022-1759(01)00350-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  In vitro selection of ribozymes dependent on peptides for activity.

Authors:  Michael P Robertson; Scott M Knudsen; Andrew D Ellington
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

Review 2.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

Review 3.  Advances and Challenges in Small-Molecule DNA Aptamer Isolation, Characterization, and Sensor Development.

Authors:  Haixiang Yu; Obtin Alkhamis; Juan Canoura; Yingzhu Liu; Yi Xiao
Journal:  Angew Chem Int Ed Engl       Date:  2021-02-09       Impact factor: 15.336

4.  In situ imaging and isolation of proteins using dsDNA oligonucleotides.

Authors:  Graham Dellaire; Rozalia Nisman; Christopher H Eskiw; David P Bazett-Jones
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

Review 5.  Aptamers and aptamer targeted delivery.

Authors:  Amy C Yan; Matthew Levy
Journal:  RNA Biol       Date:  2009-07-18       Impact factor: 4.652

Review 6.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 7.  RNA aptamer evolution: two decades of SELEction.

Authors:  Guillermo Aquino-Jarquin; Julia D Toscano-Garibay
Journal:  Int J Mol Sci       Date:  2011-12-08       Impact factor: 5.923

Review 8.  An overview and future prospects on aptamers for food safety.

Authors:  Fernanda Raquel Wust Schmitz; Alexsandra Valério; Débora de Oliveira; Dachamir Hotza
Journal:  Appl Microbiol Biotechnol       Date:  2020-06-25       Impact factor: 4.813

Review 9.  Applications of DNA-Functionalized Proteins.

Authors:  Zhaoqiu Gong; Yuanyuan Tang; Ningning Ma; Wenhong Cao; Yong Wang; Shuang Wang; Ye Tian
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 10.  Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis.

Authors:  Shruti Srivastava; Philip Raj Abraham; Sangita Mukhopadhyay
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.